HealthDay News — Adverse pregnancy outcomes (APOs) mediate a small proportion of the association between prepregnancy obesity and cardiovascular disease (CVD) risk in midlife, according to a study ...

Cumulative CV health score at age 18 to 45 years was tied to reduced CVD risk at midlife. Individuals who improved yearly cumulative Life’s Essential 8 score by midlife also shared in the CV ...

The team found between 9,000 and 10,000 daily steps were optimal to counteract a highly sedentary lifestyle, lowering incident CVD risk by 21 percent and mortality risk by 39 percent. All movement ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Empagliflozin vs placebo was associated with greater reductions in risk for cardiovascular disease among patients with type 1 diabetes. Sodium–glucose cotransporter inhibitors (SGLTis) are ...

In its final affirmative determinations for the antidumping and countervailing duty (AD/CVD) tariff investigation, the DOC announced steep tariffs on solar cell imports, whether assembled into ...

Romosozumab does not appear to significantly increase the risk for cardiovascular disease (CVD) among patients with osteoporosis when compared with bisphosphonates, according to study results ...

The U.S. Dept. of Commerce today released its final tariff amounts on solar cells (whether or not assembled into modules) from Cambodia, Malaysia, Thailand and Vietnam. The tariffs would go into ...

The association of GDM with overall CVH and predicted cardiovascular disease (CVD) risk in mid-life remains to be defined among South Asian women in the US, a subgroup at excess risk for CVD. Methods: ...

AbbVie’s shares have outperformed the Zacks Large Cap Pharmaceuticals industry over the past year (+10.2% vs. -12.5%). The Zacks analyst believes that the company’s medicines, Skyrizi and ...